c1 inh hk396  (Hycult Biotech)


Bioz Verified Symbol Hycult Biotech is a verified supplier
Bioz Manufacturer Symbol Hycult Biotech manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Hycult Biotech c1 inh hk396
    C1 Inh Hk396, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c1 inh hk396/product/Hycult Biotech
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    c1 inh hk396 - by Bioz Stars, 2024-09
    93/100 stars

    Images

    c1 inh hk396  (Hycult Biotech)


    Bioz Verified Symbol Hycult Biotech is a verified supplier
    Bioz Manufacturer Symbol Hycult Biotech manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Hycult Biotech c1 inh hk396
    C1 Inh Hk396, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c1 inh hk396/product/Hycult Biotech
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    c1 inh hk396 - by Bioz Stars, 2024-09
    93/100 stars

    Images

    masp1 c1 inhibitor complex  (Hycult Biotech)


    Bioz Verified Symbol Hycult Biotech is a verified supplier
    Bioz Manufacturer Symbol Hycult Biotech manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Hycult Biotech masp1 c1 inhibitor complex
    Detailed complement profile of the MIS-C cohort before, during and after IVIG therapy, and of healthy controls. Levels of the complement pathway (classical-, lectin- and alternative) activities, factors (C1q, C4, C3, Factors D, B and properdin) and regulators (C1-inhibitor antigen and activity, Factors H and I) were determined in serum, whereas that of activation products (C1s-C1-inhibitor complex, <t>MASP1-C1-inhibitor</t> complex, C4a, C4d, C3a, Bb and sC5b-9) in EDTA plasma. Violin plots (with dashed horizontal lines indicating the median values, dotted lines indicating the quartiles) show results for the 18 healthy control children (HC), and for all MIS-C cases who had samples from acute stage, before IVIG treatment, or from stable remission after hospital discharge. P values for the pair-wise group comparisons (HC-acute and acute-remission groups) on the violin plots were calculated by the Mann–Whitney test. Non-significant differences are not marked, and p value symbols (* p < 0.05, ** p < 0.01, *** p < 0.001) indicate significant results after 5% false discovery rate correction using the Benjamini–Hochberg method.
    Masp1 C1 Inhibitor Complex, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/masp1 c1 inhibitor complex/product/Hycult Biotech
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    masp1 c1 inhibitor complex - by Bioz Stars, 2024-09
    93/100 stars

    Images

    1) Product Images from "Evidence, detailed characterization and clinical context of complement activation in acute multisystem inflammatory syndrome in children"

    Article Title: Evidence, detailed characterization and clinical context of complement activation in acute multisystem inflammatory syndrome in children

    Journal: Scientific Reports

    doi: 10.1038/s41598-022-23806-5

    Detailed complement profile of the MIS-C cohort before, during and after IVIG therapy, and of healthy controls. Levels of the complement pathway (classical-, lectin- and alternative) activities, factors (C1q, C4, C3, Factors D, B and properdin) and regulators (C1-inhibitor antigen and activity, Factors H and I) were determined in serum, whereas that of activation products (C1s-C1-inhibitor complex, MASP1-C1-inhibitor complex, C4a, C4d, C3a, Bb and sC5b-9) in EDTA plasma. Violin plots (with dashed horizontal lines indicating the median values, dotted lines indicating the quartiles) show results for the 18 healthy control children (HC), and for all MIS-C cases who had samples from acute stage, before IVIG treatment, or from stable remission after hospital discharge. P values for the pair-wise group comparisons (HC-acute and acute-remission groups) on the violin plots were calculated by the Mann–Whitney test. Non-significant differences are not marked, and p value symbols (* p < 0.05, ** p < 0.01, *** p < 0.001) indicate significant results after 5% false discovery rate correction using the Benjamini–Hochberg method.
    Figure Legend Snippet: Detailed complement profile of the MIS-C cohort before, during and after IVIG therapy, and of healthy controls. Levels of the complement pathway (classical-, lectin- and alternative) activities, factors (C1q, C4, C3, Factors D, B and properdin) and regulators (C1-inhibitor antigen and activity, Factors H and I) were determined in serum, whereas that of activation products (C1s-C1-inhibitor complex, MASP1-C1-inhibitor complex, C4a, C4d, C3a, Bb and sC5b-9) in EDTA plasma. Violin plots (with dashed horizontal lines indicating the median values, dotted lines indicating the quartiles) show results for the 18 healthy control children (HC), and for all MIS-C cases who had samples from acute stage, before IVIG treatment, or from stable remission after hospital discharge. P values for the pair-wise group comparisons (HC-acute and acute-remission groups) on the violin plots were calculated by the Mann–Whitney test. Non-significant differences are not marked, and p value symbols (* p < 0.05, ** p < 0.01, *** p < 0.001) indicate significant results after 5% false discovery rate correction using the Benjamini–Hochberg method.

    Techniques Used: Activity Assay, Activation Assay, MANN-WHITNEY

    Key resources.
    Figure Legend Snippet: Key resources.

    Techniques Used: Binding Assay, Recombinant, Enzyme-linked Immunosorbent Assay, Software

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93
    Hycult Biotech c1 inh hk396
    C1 Inh Hk396, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c1 inh hk396/product/Hycult Biotech
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    c1 inh hk396 - by Bioz Stars, 2024-09
    93/100 stars
      Buy from Supplier

    93
    Hycult Biotech masp1 c1 inhibitor complex
    Detailed complement profile of the MIS-C cohort before, during and after IVIG therapy, and of healthy controls. Levels of the complement pathway (classical-, lectin- and alternative) activities, factors (C1q, C4, C3, Factors D, B and properdin) and regulators (C1-inhibitor antigen and activity, Factors H and I) were determined in serum, whereas that of activation products (C1s-C1-inhibitor complex, <t>MASP1-C1-inhibitor</t> complex, C4a, C4d, C3a, Bb and sC5b-9) in EDTA plasma. Violin plots (with dashed horizontal lines indicating the median values, dotted lines indicating the quartiles) show results for the 18 healthy control children (HC), and for all MIS-C cases who had samples from acute stage, before IVIG treatment, or from stable remission after hospital discharge. P values for the pair-wise group comparisons (HC-acute and acute-remission groups) on the violin plots were calculated by the Mann–Whitney test. Non-significant differences are not marked, and p value symbols (* p < 0.05, ** p < 0.01, *** p < 0.001) indicate significant results after 5% false discovery rate correction using the Benjamini–Hochberg method.
    Masp1 C1 Inhibitor Complex, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/masp1 c1 inhibitor complex/product/Hycult Biotech
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    masp1 c1 inhibitor complex - by Bioz Stars, 2024-09
    93/100 stars
      Buy from Supplier

    Image Search Results


    Detailed complement profile of the MIS-C cohort before, during and after IVIG therapy, and of healthy controls. Levels of the complement pathway (classical-, lectin- and alternative) activities, factors (C1q, C4, C3, Factors D, B and properdin) and regulators (C1-inhibitor antigen and activity, Factors H and I) were determined in serum, whereas that of activation products (C1s-C1-inhibitor complex, MASP1-C1-inhibitor complex, C4a, C4d, C3a, Bb and sC5b-9) in EDTA plasma. Violin plots (with dashed horizontal lines indicating the median values, dotted lines indicating the quartiles) show results for the 18 healthy control children (HC), and for all MIS-C cases who had samples from acute stage, before IVIG treatment, or from stable remission after hospital discharge. P values for the pair-wise group comparisons (HC-acute and acute-remission groups) on the violin plots were calculated by the Mann–Whitney test. Non-significant differences are not marked, and p value symbols (* p < 0.05, ** p < 0.01, *** p < 0.001) indicate significant results after 5% false discovery rate correction using the Benjamini–Hochberg method.

    Journal: Scientific Reports

    Article Title: Evidence, detailed characterization and clinical context of complement activation in acute multisystem inflammatory syndrome in children

    doi: 10.1038/s41598-022-23806-5

    Figure Lengend Snippet: Detailed complement profile of the MIS-C cohort before, during and after IVIG therapy, and of healthy controls. Levels of the complement pathway (classical-, lectin- and alternative) activities, factors (C1q, C4, C3, Factors D, B and properdin) and regulators (C1-inhibitor antigen and activity, Factors H and I) were determined in serum, whereas that of activation products (C1s-C1-inhibitor complex, MASP1-C1-inhibitor complex, C4a, C4d, C3a, Bb and sC5b-9) in EDTA plasma. Violin plots (with dashed horizontal lines indicating the median values, dotted lines indicating the quartiles) show results for the 18 healthy control children (HC), and for all MIS-C cases who had samples from acute stage, before IVIG treatment, or from stable remission after hospital discharge. P values for the pair-wise group comparisons (HC-acute and acute-remission groups) on the violin plots were calculated by the Mann–Whitney test. Non-significant differences are not marked, and p value symbols (* p < 0.05, ** p < 0.01, *** p < 0.001) indicate significant results after 5% false discovery rate correction using the Benjamini–Hochberg method.

    Article Snippet: MASP1-C1-inhibitor complex, Human, ELISA Kit , Hycult biotech , Cat# HK3001*.

    Techniques: Activity Assay, Activation Assay, MANN-WHITNEY

    Key resources.

    Journal: Scientific Reports

    Article Title: Evidence, detailed characterization and clinical context of complement activation in acute multisystem inflammatory syndrome in children

    doi: 10.1038/s41598-022-23806-5

    Figure Lengend Snippet: Key resources.

    Article Snippet: MASP1-C1-inhibitor complex, Human, ELISA Kit , Hycult biotech , Cat# HK3001*.

    Techniques: Binding Assay, Recombinant, Enzyme-linked Immunosorbent Assay, Software